AHA Launcher and Director, Science and Technology Accelerator Venture Capital Division
Cardiology
Dr. Ross M. Tonkens, MD
|
|
Give Review
Ross M. Tonkens works in the field of Cardiology. He graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. Ross Tonkens is also published. He has 7 publications published. The lastest publication: "First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.'
Publications
- First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.
- Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.
- Breaking into clinical research.
- A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor.
- Clinical research organizations offer wide range of management opportunities for physician executives.
- An overview of the drug development process.
Schools
Yale University School Of Medicine
Cedars Sinai Med Center
UCLA Center Health Science
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Education
-
Yale University School of Medicine -
Cedars-Sinai Medical Center -
UCLA Medical Center -
Yale College
Helpful Reviews
Similar Doctors
|
|
Dr. Kenneth J. Shah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chandrasekhar R. Narala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda L. Johnson, MD |
|
|
Dr. Jeffrey M. Levisman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik Sirulnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfonso L. Tiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Navratil, MD
This Doctor is OpenDoctor Recommended.
|